Find a TenderOpen for tender
Published 9 Oct 2026, 09:06 BST

Official UK procurement notice

NP93827 Seasonal Influenza Vaccine

Authority: The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

3 lotsGoodsOpen procedure
Published estimate£19,000,000envelope for 3 lots
Submission deadline 9 Nov 202612:00 GMT · 30d 10h left
Lots 3see the lot list below

What is being bought3 lots · detail below

Published requirement description

Supply of Seasonal Influenza Vaccine.

CPV: Pharmaceutical products

Lots and requirements (3)Procurement structure

3 lots · all with a published value (£19,200,000 together) · same evaluation weights on every lot
Lot #1Flu Vaccines for Over-65s as recommended by JCVI for 2027/28Published value£13,708,000
Lot 1 - Supply of Influenza Vaccines as recommended by JCVI for Over 65 years to NHS Scotland for use in the 2027/28 NHS Scotland Seasonal Flu Programme. The authority intends to award this Lot as a commitment contract to a single supplier. Any bidder that submits a bid for the same vaccine for both Lot 1 and Lot 2 will only be eligible for award to one of the Lots. Full details of the goods and volumes can be found within the ITT documents.
Delivery: ScotlandTurnover guideline: ~£27,416,000/yr≈ 2× annual value
Variant bids
not allowed
33600000 Pharmaceutical products

Who is likely to bid for this lot ↓

Lot #2Flu Vaccines for Under-65s as recommended by JCVI for 2027/28Published value£5,200,000
Lot 2 - Supply of influenza vaccines as recommended by JCVI for Under 65 years to NHS Scotland for use in the 2027/28 Seasonal Flu Programme. The authority intends to award this lot as a commitment contract to a single supplier. Any bidder that submits a bid for the same vaccine for both lot 1 and lot 2 will only be eligible for award to one of those lots. Details of the goods and volumes can be found within the ITT documents.
Delivery: ScotlandTurnover guideline: ~£10,400,000/yr≈ 2× annual value
Variant bids
not allowed
33600000 Pharmaceutical products

Who is likely to bid for this lot ↓

Lot #3Flu Vaccines for 6 months to 17 years for those contraindicated to LAIV as recommended by JCVI for the 2027/28 flu programmePublished value£292,000
Lot 3 - Supply of influenza vaccines as recommended by JCVI for 6 months to 17 years contraindicated to LAIV for NHS Scotland for use in the 2027/28 Seasonal Flu Programme. The authority intends to award this lot as a commitment contract to a single supplier. Full details of the goods and volumes can be found within the ITT documents.
Delivery: ScotlandTurnover guideline: ~£584,000/yr≈ 2× annual value
Variant bids
not allowed
33600000 Pharmaceutical products

Who is likely to bid for this lot ↓

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published — the tender pack may add more
How bids are scored · same split on all 3 lots
Quality: 10%Price: 90%
Published sub-criteria (2)
  • Delivery Timetable — 10%
  • price — 90%
Published award criteria (2)
  • Delivery Timetable — 10
  • Price — 90
Conditions of participation2
  • Suitability
    Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
  • Technical & professional ability
    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
What this means for your bid
  • Price carries 90 of 100 points — a 10% discount moves about 9 points. This one is won on the number — sharpen the price before polishing the prose.
  • Turnover usually expected: about £584,000 – ~£27,416,000 per lot (twice each lot's annual value).

Price arithmetic assumes straight proportional scoring — the tender pack may use another formula. Turnover is an indicative market norm (≈2× annual value), not a published condition.

Competition analysis · published record, not a forecast of who will bid

How The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) runs Pharmaceutical products (CPV 3360) tenders for its clients — and who usually turns up

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) procures on behalf of other bodies; its record below covers every client it has tendered for, next to the Scotland market for the same work. Frameworks and DPS are kept out: they attract a different number of bids. Whole-market view: Pharmaceutical products (CPV 3360) →

1

How the contest usually goes

This buyer’s published record next to the market where the work is delivered — contested contracts only, counted per lot

How often do SMEs win?
i

How often small and medium firms win.

Share of awards where the winner’s size is known.

The counts under this question show how many awards have a known supplier size.

Last 36 months.

Buyer: 8 of 30 known-size awards · market: CPV 3360, n=7
27%0%

Small firms have won here. Neither number says whether you qualify; it describes who has been winning.

How often do local suppliers win?
i

How often local firms win similar work.

Winners with a registered address in the delivery region, out of awards with a known address.

Here, local means registered in Scotland.

A local branch does not count if the registered address is elsewhere.

Last 36 months.

Buyer: 8 of 15 known-location awards · market: CPV 3360, n=11
53%64%

Most of this buyer’s recorded winners are registered in Scotland.

How long to a decision?
i

How long buyers here take to decide after bids close.

Middle value in days from the deadline to the first award notice, on competitions that published both dates.

Only decided tenders count, so slow ones still waiting are not in.

Last 36 months.

Buyer: no dates · market: no dates
——

No published decision dates to compare.

How often single-bid or direct?
i

How often work is awarded with no recorded rival.

Direct awards and tenders where every published lot count shows one bid.

Both shares are minimums: some awards have no bid count.

Thin markets produce this too; it is not proof of a tailored specification.

Last 36 months.

Buyer: at least 7 of 16 awarded contracts without a rival · market: n=9
44%22%

Direct awards or one recorded bid are common here. Check the route before spending time on a bid.

How many bids did past lots attract?

i

How many bids past lots received.

Each colour is a bid-count range. Only competed lots with a published count are included.

Past bids do not predict this tender.

Last 36 months.

This buyer16 lots with bid counts · all categories
19% had one bid
The market8 lots with bid counts · CPV 3360
38% had one bid
Buyer / market · select a colour for counts
1 bid19% / 38%
Buyer: 3 of 16 lots with published bid counts. Market: 3 of 8 lots with published bid counts.
2–350% / 25%
Buyer: 8 of 16 lots with published bid counts. Market: 2 of 8 lots with published bid counts.
4–625% / 25%
Buyer: 4 of 16 lots with published bid counts. Market: 2 of 8 lots with published bid counts.
7+6% / 13%
Buyer: 1 of 16 lots with published bid counts. Market: 1 of 8 lots with published bid counts.

How did awards compare with estimates?

i

Where winning prices landed against estimates.

Each colour shows awards below, close to or above the published estimate, one lot at a time.

Past prices are a guide, not a bid price.

Last 36 months.

This buyerNo matched awards
—
The market27 lots with estimate and award · broad CPV 33
33% below estimate
Market · select a colour for counts
Below estimate33%
Market: 9 of 27 lots with an estimate and award.
Within ±2%30%
Market: 8 of 27 lots with an estimate and award.
Above estimate37%
Market: 10 of 27 lots with an estimate and award.
2

Assess each lot
i

What past awards tell you about each lot.

See the forecast, this buyer’s earlier suppliers and firms with relevant wins.

No supplier is confirmed as a bidder.

Open a lot for its forecast, this buyer’s previous supplier and possible competitors — from published award history, not a bid list

Lot #1Flu Vaccines for Over-65s as recommended by JCVI for 2027/28CPV 336024% single-bidPublished estimate£13,708,000
Expected competition
i

How many bids this lot may attract.

The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 89 past lots.

A forecast, not a list of bidders.

—24% single-bid risk
Past bids on 89 similar lots
1 bid24%
21 of 89 similar past lots received 1 bid (24%).
2–329%
26 of 89 similar past lots received 2–3 (29%).
4–631%
28 of 89 similar past lots received 4–6 (31%).
7+16%
14 of 89 similar past lots received 7+ (16%).
Comparable past lots usually drew 3 bids.
Commercial price forecast
i

Where the winning price may land.

The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.

No comparable awards for this lot yet.

A guide, not a price to bid.

—No model forecast yet
No comparable awards on record for this lot’s category yet — the published estimate is £14m, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

Who has done similar work for this buyer.

Past contracts are matched by buyer, title and type of work.

A past supplier may not bid again.

SupplierThis buyer’s earlier contractLotAward valueMatch
—

Who could compete for this lot?
i

Who could compete for this lot?

Firms with relevant past wins. On a framework, we show firms on that agreement.

None is confirmed as a bidder.

SupplierWon in this categoryLive contractsAward vs estimate
—
Lot #2Flu Vaccines for Under-65s as recommended by JCVI for 2027/28CPV 336024% single-bidPublished estimate£5,200,000
Expected competition
i

How many bids this lot may attract.

The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 89 past lots.

A forecast, not a list of bidders.

—24% single-bid risk
Past bids on 89 similar lots
1 bid24%
21 of 89 similar past lots received 1 bid (24%).
2–329%
26 of 89 similar past lots received 2–3 (29%).
4–631%
28 of 89 similar past lots received 4–6 (31%).
7+16%
14 of 89 similar past lots received 7+ (16%).
Comparable past lots usually drew 3 bids.
Commercial price forecast
i

Where the winning price may land.

The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.

No comparable awards for this lot yet.

A guide, not a price to bid.

—No model forecast yet
No comparable awards on record for this lot’s category yet — the published estimate is £5.2m, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

Who has done similar work for this buyer.

Past contracts are matched by buyer, title and type of work.

A past supplier may not bid again.

SupplierThis buyer’s earlier contractLotAward valueMatch
—

Who could compete for this lot?
i

Who could compete for this lot?

Firms with relevant past wins. On a framework, we show firms on that agreement.

None is confirmed as a bidder.

SupplierWon in this categoryLive contractsAward vs estimate
—
Lot #3Flu Vaccines for 6 months to 17 years for those contraindicated to LAIV as recommended by JCVI for the 2027/28 flu programmeCPV 336024% single-bidPublished estimate£292,000
Expected competition
i

How many bids this lot may attract.

The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 89 past lots.

A forecast, not a list of bidders.

—24% single-bid risk
Past bids on 89 similar lots
1 bid24%
21 of 89 similar past lots received 1 bid (24%).
2–329%
26 of 89 similar past lots received 2–3 (29%).
4–631%
28 of 89 similar past lots received 4–6 (31%).
7+16%
14 of 89 similar past lots received 7+ (16%).
Comparable past lots usually drew 3 bids.
Commercial price forecast
i

Where the winning price may land.

The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.

No comparable awards for this lot yet.

A guide, not a price to bid.

—No model forecast yet
No comparable awards on record for this lot’s category yet — the published estimate is £292k, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

Who has done similar work for this buyer.

Past contracts are matched by buyer, title and type of work.

A past supplier may not bid again.

SupplierThis buyer’s earlier contractLotAward valueMatch
—

Who could compete for this lot?
i

Who could compete for this lot?

Firms with relevant past wins. On a framework, we show firms on that agreement.

None is confirmed as a bidder.

SupplierWon in this categoryLive contractsAward vs estimate
—
Coverage and what to read with care
  • Each figure explains itself. The on a figure says what it is, how it is counted and which scope this notice’s own record came from (class, division, all categories, or the authority’s 24-month row). The two sides are never blended. A lot’s own market is read at its delivery region where the lot names one; where it names several, or none that can be resolved, the chart falls back to the UK-wide record for the same category and says so under the bar. An empty cell means the source published nothing usable. Long form: Methodology.
  • When we call out a difference. A buyer figure is only flagged against the market when the sample is large enough that the gap is unlikely to be chance; at most two callouts appear, always phrased as a comparison with both numbers and the sample size.
  • Coverage (re-measured 5 Oct on the live record, 94,497 awarded procedures of the last three years). 51 % publish a bid count and 72 % a delivery region, so the market column reads the authority’s registered region when the notice names none, labelled. Of the 17,687 award-vs-estimate pairs, 34 % sit exactly on the estimate — the buyer published the award at the figure it advertised. n is on every figure; a thin sample is muted, never hidden, and a distribution is not drawn as percentages below ten observations.
  • “Match”, text similarity, the expected-bid figure and the distribution drawn beneath it are model outputs, not published facts or win probabilities. Find a Tender does not publish who is bidding. Never shown: contact details, payment behaviour, or a recommended price.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Open for tender
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
9 Oct 2026, 09:06 BST
Last source update
9 Oct 2026, 09:06 BST
Award evaluation window
9 Nov 2026 — …
FTS notice number
2026/S 000-095463
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-07844a Find a Tender
Contract terms
Electronic trading
electronic ordering
Review and risk notes
Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the 12 month contract duration. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 32871. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants/contractors agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework/contract. Potential framework participants/contractors are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential contractors are required to summarise any proposed community benefits that will be developed and delivered as part of this contract if successful or, alternatively, potential contractors confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:845305)

How to participate & submission route

Official notice Submit via Public Contracts Scotland
Submission portal named on this notice: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Requests to participate (first stage)
—
Tender submission deadline
9 Nov 2026, 12:00 GMT
Clarification deadline
—
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
9 Nov 2026, 12:00 GMT
Detailed submission instructions & authority contactsFrom official release

Timeline

3 published dates · Europe/London
  1. Notice published1 day ago
    9 Oct 2026, 09:06 BST
  2. Submission deadlinein 30 days
    9 Nov 2026, 12:00 GMT
  3. Bids openedin 30 days
    9 Nov 2026, 12:00 GMT

Commercial outcome & contract awards

Nothing awarded yet
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Contracting authorityBody governed by public lawHealth 1 South Gyle Crescent., Edinburgh, Scotland, EH12 9EB Michael Welsh [email protected] +44 1312756000 Published organisation website ↗

Dispute resolution & review bodies

Official documents & specifications (1)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria